The American Journal of Psychiatry
Official Journal of the American Psychiatric Association
Edited by Robert Freedman, M.D.4 of Journal Watch Psychiatry’s 10 “Top Stories of 2012”
appeared in The American Journal of Psychiatry
. No other journal had multiple appearances.
The American Journal of Psychiatry’s latest Impact Factor is 12.539 according to the recently released 2011 Journal Citation Reports® (Thomson Reuters, 2012), placing it second among 129 journals in psychiatry while still remaining the far-and-away leader in total citations.
The American Journal of Psychiatry Named in Top 100 Journals in Biology and Medicine
The American Journal of Psychiatry was voted one of the 100 Most Influential Journals in Biology & Medicine over the last 100 Years by members of the BioMedical & Life Sciences Division (DBIO) of the Special Libraries Association (SLA) as part of its Centennial celebrations. Learn more.
The American Journal of Psychiatry
is the most widely read psychiatric journal in the world. Published monthly, it is an indispensable journal for all psychiatrists and other mental health professionals who need to stay on the cutting edge of virtually every aspect of psychiatry. Reviews and overviews help with information to prepare for recertification and original research provides information on the latest advances in diagnosis, treatment, neuroscience, and patient populations.
- The American Journal of Psychiatry’s latest Impact Factor is 12.759, a rise from last year's 12.522 and 2-point rise from the previous year's 10.545, according to the recently released 2010 Journal Citation Reports® (Thomson Reuters, 2011). AJP, a publication of the American Psychiatric Association, ranks second among 126 journals in psychiatry.
- The American Journal of Psychiatry (AJP) is again the #1 journal in psychiatry in terms of immediacy according to Thomson Scientific’s Immediacy Index. This important performance metric is calculated by dividing the number of citations to articles published in a given year by the number of articles published in that year. The Immediacy Index is a good measure of how quickly a given journal’s articles are cited—AJP’s #1 placement is a result of publishing articles that are relevant, covering current “hot” topics and cutting-edge research, and getting these findings to the field faster with AJP in Advance, the Journal’s online-ahead-of-print publication protocol.
- A recent poll conducted by the BioMedical & Life Sciences Division of The Special Libraries Association identified the 100 most influential journals in all of Biology & Medicine over the last 100 years. The American Journal of Psychiatry was among those honored, the only psychiatry/psychology journal represented.
The American Journal of Psychiatry is committed to keeping the field of psychiatry vibrant and relevant by publishing the latest advances in the diagnosis and treatment of mental illness. The findings presented in this journal explore the full spectrum of issues related to mental health diagnoses and treatment with editorials that place the most groundbreaking research into clinical context.
- AJP in Advance—As part of the Journal's commitment to bringing the latest research to the field faster, all research articles now appear online in advance of their appearance in a print issue. AJP in Advance is updated with new articles on the 1st and 15th of each month (or the next business day).
- Treatment in Psychiatry Series—Leading experts provide a hypothetical case vignette on a commonly encountered issue in patient care followed by a summary of the relevant research literature, plus offers recommendations of how to proceed with assessment and treatment.
- Clinical Case Conference Series—Complements the Treatment in Psychiatry series by giving additional practice oriented guidance by presenting actual patients (with disguised identities) who pose especially difficult or unique problems in diagnosis and treatment.
- AJP Audio—Each online issue includes a 30-minute downloadable .mp3 format program that contains highlights and selected findings from the issue.
- Residents Journal—Each online issue is also accompanied by a FREE electronic publication produced specifically for psychiatry residents that features instructive cases, perspectives on training and career development, and discussions of unique clinical or educational programs along with special instructional columns from AJP Editors.
No other psychiatric journal reaches more psychiatrists with greater impact or immediacy than The American Journal of Psychiatry, the journal that the overwhelming majority of psychiatrists consider essential: Each issue covers issues on:
- Disorders—substance abuse, childhood psychopathology, mood disorders, and personality disorders
- Treatment—psychopharmacology, psychotherapy, and ECT
- Neuroscience—brain imaging, genetics, and molecular biology
- Patient populations—women, the elderly, children, and veterans
CME is now available from The American Journal of Psychiatry!
AJP CME can help you fulfill your CME requirement while staying current on the latest advances in psychiatry. Brief companion exams are created for three of the most influential articles from each issue. By reading the articles and completing the online exams, you can test your knowledge and earn up to 1 AMA PRA Category 1 Credits per article. For more information and pricing, please go to http://cme.psychiatryonline.org
To visit the American Journal of Psychiatry online, please visit http://ajp.psychiatryonline.org
In This Issue: April 2013
April’s AJP includes a proof-of-concept study showing that immunization with a nicotine vaccine over 20 weeks led to an average 12.5% reduction in the binding of administered nicotine to �2*-nicotinic acetylcholine receptors, a 23.6% decrease in the amount of nicotine available to enter the brain, along with decreases in craving and the number of cigarettes smoked in 11 long-term smokers. Also in the April issue are a study showing significantly greater risk for autism spectrum disorder in children who have restricted or unusually large fetal growth and another study examining addiction in active duty U.S. Airmen following mild TBI.
Robert Freedman, M.D., is Professor and Chair of Psychiatry at the University of Colorado. He is a graduate of Harvard Medical School and a member of the Institute of Medicine of the National Academies of Science. He was recently confirmed for membership into the Dana Alliance for Brain Initiatives, a nonprofit organization whose members are among the world's foremost authorities on neuroscientific research and clinical neurology topics.
Robert Freedman, M.D.
David A. Lewis, M.D.
Robert Michels, M.D.
Daniel S. Pine, M.D.
Susan K. Schultz, M.D.
Carol A. Tamminga, M.D.
Kathleen T. Brady, M.D., Ph.D.
David A. Brent, M.D.
Linda Brzustowicz, M.D.
Cameron S. Carter, M.D.
Howard H. Goldman, M.D., Ph.D.
Daniel C. Javitt, M.D.
Bankole Johnson, M.D.
Ellen Leibenluft, M.D.
Jeffrey A. Lieberman, M.D.
Barbara Milrod, M.D.
Maria A. Oquendo, M.D.
Jerrold F. Rosenbaum, M.D.
A. John Rush, M.D.
Larry J. Siever, M.D.
Patricia Suppes, M.D., Ph.D.
Myrna M. Weissman, Ph.D.
Nancy C. Andreasen, M.D., Ph.D.
Amariah Brigham, M.D., 1844�1849
T. Romeyn Beck, M.D., 1849�1854
John P. Gray, M.D., 1854�1886
G. Alder Blumer, M.D., 1886�1894
Richard Dewey, M.D., 1894�1897
Henry M. Hurd, M.D., 1897�1904
Edward N. Brush, M.D., 1904�1931
Clarence B. Farrar, M.D., 1931�1965
Francis J. Braceland, M.D., 1965�1978
John C. Nemiah, M.D., 1978�1993